Table 3 Renal Adverse Events: Prior to Multivariable Modeling (Unadjusted)
| Â | Renal Adverse Event Outcome | Components of the Renal Adverse Events Outcome | |||
|---|---|---|---|---|---|
Acute Kidney Injury without dialysis | Acute Kidney Injury with dialysis | CI-AKI | Renal Failure | ||
Baseline | 0.5% | 0.5% | 0.0% | 0.0% | 0.0% |
No CKD | 0.9% | 0.8% | 0.0% | 0.0% | 0.0% |
CKD Stage 1 | 6.1% | 6.0% | 0.1% | 0.2% | 0.0% |
CKD Stage 2 | 8.4% | 8.3% | 0.1% | 0.2% | 0.0% |
CKD Stage 3 | 11.4% | 11.1% | 0.3% | 0.3% | 0.1% |
CKD Stage 4&5 | 12.7% | 11.6% | 0.8% | 0.3% | 0.2% |
CT | 2.8% | 2.6% | 0.1% | 0.1% | 0.0% |
No CT | 1.3% | 1.3% | 0.0% | 0.0% | 0.0% |
CT with Iodinated Contrast | 2.9% | 2.8% | 0.1% | 0.1% | 0.0% |
CT without Iodinated Contrast | 2.7% | 2.6% | 0.1% | 0.1% | 0.0% |
No-Cancer | 1.4% | 1.3% | 0.0% | 0.0% | 0.0% |
Cancer | 3.0% | 2.9% | 0.1% | 0.0% | 0.0% |
 Bone | 1.4% | 1.3% | 0.1% | 0.0% | 0.0% |
 Breast | 0.6% | 0.6% | 0.0% | 0.0% | 0.0% |
 Colorectal | 4.1% | 4.0% | 0.1% | 0.0% | 0.0% |
 Endocrine | 1.5% | 1.5% | 0.1% | 0.0% | 0.0% |
 Gastrointestinal | 3.3% | 3.2% | 0.1% | 0.1% | 0.0% |
 Gynecological | 2.5% | 2.4% | 0.1% | 0.0% | 0.0% |
 Hemolymph | 3.9% | 3.5% | 0.3% | 0.1% | 0.1% |
 Leukemia | 5.3% | 4.9% | 0.3% | 0.1% | 0.1% |
 Liver | 4.3% | 4.0% | 0.2% | 0.1% | 0.1% |
 Lung | 2.8% | 2.7% | 0.1% | 0.1% | 0.0% |
 Miscellaneous | 1.9% | 1.9% | 0.0% | 0.0% | 0.0% |
 Neurological | 1.0% | 0.9% | 0.0% | 0.0% | 0.0% |
 Respiratory | 2.2% | 2.2% | 0.0% | 0.0% | 0.0% |
 Skin | 1.6% | 1.6% | 0.0% | 0.0% | 0.0% |
 Urinary | 4.1% | 4.0% | 0.1% | 0.0% | 0.0% |